Clinical AI company Sensyne Health has signed a five-year strategic research agreement (SRA) with Milton Keynes University Hospital Foundation Trust (MKUH).
Clinical AI company Sensyne Health has signed a research collaboration agreement with Bristol Myers Squibb to apply machine learning for rare blood disease research.
Digital health company Sensyne Health announced plans to go public with a £60 million listing ($77 million) on the alternative investment market of the London Stock Exchange on Aug. 17.